Concepedia

Author

Christine Pirker

Medical University of ViennaORCID

Also Known As

C Pirker, C. Pirker, Christine Pirker, Pirker, C., Pirker, Christine

240

Publications

4K

Citations

35

H-Index

109

Concepts

All Affiliations

Medical University of ViennaComprehensive Cancer Center ViennaUniversity of ViennaSemmelweis UniversityOrszágos Korányi Tbc és Pulmonológiai Intézet
CP

About

Christine Pirker is an author at Medical University of Vienna specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

29

1.2K

2

Health Sciences

5

5

222

3

Natural Sciences

3

3

47

4

Allergy

1

1

13

5

Allergy Medicine

1

1

13

Christine Pirker

×

78

Publications

3.4K

Citations

34

H-Index

YearCitations

<i>EGFR/KRAS/BRAF</i> Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases

Katharina Schmid, Natalie Oehl, Fritz Wrba,

Clinical Cancer Research

2009

262

<i>TERT</i>promoter mutations are associated with poor prognosis and cell immortalization in meningioma

Sabine Spiegl‐Kreinecker, Daniela Lötsch, Katharina Neumayer,

Neuro-Oncology

2018

132

Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis

Sabine Spiegl‐Kreinecker, Daniela Lötsch, Bahil Ghanim,

Neuro-Oncology

2015

130

The sodium pump α1 sub‐unit: a disease progression–related target for metastatic melanoma treatment

Véronique Mathieu, Christine Pirker, Elisabeth Martin de Lassalle,

Journal of Cellular and Molecular Medicine

2009

125

Targeting of eEF1A with <i>Amaryllidaceae</i> isocarbostyrils as a strategy to combat melanomas

Gwendoline Van Goietsenoven, Jenna Hutton, Jean‐Paul Becker,

The FASEB Journal

2010

122

Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)

Petra Heffeter, Michael A. Jakupec, Wilfried Körner,

Biochemical Pharmacology

2007

95

O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients

Sabine Spiegl‐Kreinecker, Christine Pirker, Martin Filipits,

Neuro-Oncology

2009

89

The major vault protein is responsive to and interferes with interferon-γ-mediated STAT1 signals

Elisabeth Steiner, Klaus Holzmann, Christine Pirker,

Journal of Cell Science

2006

85

Fibroblast Growth Factor Receptors as Therapeutic Targets in Human Melanoma: Synergism with BRAF Inhibition

Thomas Metzner, A Bedeir, Gerlinde Held,

Journal of Investigative Dermatology

2011

74

EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance

Florian Sevelda, Lisa Mayr, Bernd Kubista,

Journal of Experimental & Clinical Cancer Research

2015

73

Page 1